Thyroid cancer does not have a single cause. It develops from a combination of genetic susceptibility, environmental exposures, hormonal influences, and sometimes just bad luck at the cellular level. The strongest established external risk factor is radiation exposure during childhood, but most people diagnosed with thyroid cancer were never exposed to significant radiation. Instead, a web of interacting factors shapes who develops the disease and which type they get.
Radiation Exposure Is the Best-Documented External Cause
Of all the environmental triggers studied, ionizing radiation delivered to the neck region during childhood has the clearest link to thyroid cancer. The risk rises with the dose absorbed by the thyroid gland and falls sharply with the age at which the exposure happens. Doses as low as 50 to 100 milligray appear to push the risk upward, and the younger the person at the time of exposure, the greater the danger.1PubMed Central. Radiation exposure and thyroid cancer: a review In adults, the same dose produces far less risk.
A long-running study of people who received scalp irradiation for a fungal infection as children found that the excess risk of thyroid cancer peaked roughly 20 to 30 years after exposure and, while it dropped substantially after 40 years, remained elevated for decades.2PubMed. Risk of thyroid cancer after childhood exposure to ionizing radiation for tinea capitis This long latency period means that someone exposed as a young child could develop thyroid cancer well into middle age. Nuclear accidents like Chernobyl and Fukushima reinforced the same pattern: children living downwind faced the highest thyroid cancer rates in the years and decades that followed.
Medical radiation is worth mentioning separately. Repeated CT scans of the head and neck, radiation therapy for childhood cancers, and older dental X-ray practices all deliver some dose to the thyroid. Modern imaging uses much lower doses and better shielding than in past decades, but people who underwent radiation therapy to the head or neck region as children remain at elevated risk and are typically monitored with periodic thyroid exams.
Genetic Mutations That Drive Thyroid Tumors
Inside most thyroid tumors, researchers find specific mutations in signaling pathways that tell cells when to grow. The most common is a mutation called BRAF V600E, found in roughly half of papillary thyroid cancers, the most frequently diagnosed type. This mutation flips on a growth-signaling pathway and simultaneously shuts down the genes that help thyroid cells absorb iodine and behave like normal thyroid tissue.3PubMed Central. BRAF V600E in thyroid cancer: navigating prognostic uncertainty and therapeutic opportunity Animal experiments have confirmed that BRAF V600E can initiate tumor formation in thyroid cells, not merely accelerate an existing cancer.4PubMed. BRAF mutation in papillary thyroid carcinoma: pathogenic role and clinical implications
Another common genetic event is a rearrangement of the RET gene, known as RET/PTC. Both BRAF mutations and RET/PTC rearrangements activate the same growth-promoting signaling cascade, and they rarely occur together in the same tumor. Their presence correlates with how aggressive the cancer behaves and how well it responds to radioactive iodine therapy.5PubMed. RET/PTC rearrangements and BRAF mutations in thyroid tumorigenesis Understanding which mutation a tumor carries increasingly guides treatment decisions.
These are somatic mutations, meaning they arise in thyroid cells during a person’s lifetime rather than being inherited from a parent. What causes them to appear in the first place is not always clear. Radiation exposure is known to produce RET/PTC rearrangements, but many BRAF-mutated tumors occur in people with no identifiable environmental exposure. Epigenetic changes, where chemical modifications to DNA alter gene activity without changing the DNA sequence itself, also contribute. Abnormal DNA methylation patterns can silence tumor-suppressor genes, removing the brakes that normally keep cell growth in check.6PubMed Central. The role of epigenetic methylations in thyroid Cancer
Family History and Hereditary Syndromes
About 5 to 10 percent of non-medullary thyroid cancers (the papillary and follicular types that make up the vast majority of cases) cluster in families. The formal term for this is familial non-medullary thyroid carcinoma, generally defined as two or more first-degree relatives being diagnosed in the absence of a known genetic syndrome.7PubMed Central. Familial non-medullary thyroid carcinoma: a critical review If your parent or sibling had thyroid cancer, your own risk is meaningfully higher than average, though researchers still have not pinpointed a single gene responsible for most familial cases.
Several inherited genetic syndromes carry a well-defined thyroid cancer risk. Cowden syndrome, caused by mutations in the PTEN gene, raises the risk of differentiated thyroid cancer substantially. In one study, about 20 percent of Cowden syndrome patients were diagnosed with the disease, and they tended to develop it at a younger age than the general population.8PubMed Central. Occurrence and Natural History of Thyroid Cancer in Patients with Cowden Syndrome Familial adenomatous polyposis (FAP), a syndrome better known for colon polyps, also increases thyroid cancer risk, particularly a subtype called cribriform-morular variant of papillary carcinoma.
Medullary thyroid cancer has its own hereditary story. It arises from a different cell type than papillary or follicular cancers and is strongly tied to inherited RET mutations in conditions like multiple endocrine neoplasia type 2 (MEN2). Relatives of patients diagnosed with early-onset MEN2B face dramatically elevated lifetime risks of developing medullary thyroid cancer.9PubMed. Risk of thyroid cancer in relatives of patients with medullary thyroid carcinoma by age at diagnosis Genetic testing of family members is standard practice in these families, and preventive thyroid removal is sometimes recommended in childhood.
Why Women Are Diagnosed Far More Often Than Men
Thyroid cancer is roughly three times more common in women than in men, a gap that appears after puberty and narrows again after menopause. That timing strongly implicates estrogen. Research shows that estrogen acts as a growth factor for both benign and malignant thyroid cells, driving proliferation through pathways that involve estrogen receptors on the cell surface and inside the nucleus.10PubMed. Estrogen and its role in thyroid cancer The fact that thyroid cancer incidence rises in women only after puberty and then drops after menopause lines up closely with the years of highest estrogen exposure.11PubMed Central. Signal Pathway of Estrogen and Estrogen Receptor in the Development of Thyroid Cancer
That said, estrogen probably isn’t the whole story. Women also interact with the healthcare system more frequently during their reproductive years, which means more opportunities for incidental detection of a thyroid nodule during neck exams or imaging for other reasons. The degree to which the sex gap reflects biology versus detection bias remains an open question. When cases are diagnosed at a similar stage, men actually tend to have worse outcomes, suggesting that male thyroid cancers may be biologically more aggressive even though they are less common.
Iodine Intake Shapes Which Type of Thyroid Cancer Develops
Iodine is essential for producing thyroid hormones, and the amount of it in a population’s diet appears to influence thyroid cancer patterns. Iodine deficiency is a risk factor for thyroid cancer overall, and the evidence is strongest for follicular and anaplastic types. When populations adopt iodine supplementation programs, rates of follicular and anaplastic thyroid cancer tend to drop, while papillary thyroid cancer becomes proportionally more common.12PubMed Central. Iodine intake as a risk factor for thyroid cancer: a comprehensive review of animal and human studies
This shift in cancer subtypes has been documented in multiple countries. In regions of China, the ratio of papillary to follicular thyroid cancer increased dramatically after universal salt iodization was introduced, with papillary cancers coming to represent 80 to 90 percent of thyroid malignancies compared with around 55 percent before supplementation.13Hematology & Medical Oncology. Dietary iodine intake, thyroid diseases and the prevalence of papillary carcinoma (PTC) The mechanism behind iodine deficiency’s effect likely involves chronic overstimulation of the thyroid gland by thyroid-stimulating hormone (TSH), which rises when iodine is scarce and drives cell proliferation.14PubMed Central. Association between thyroid stimulating hormone levels and papillary thyroid cancer risk: A meta-analysis
The overall picture is that iodine nutrition shapes the landscape of thyroid cancer rather than simply increasing or decreasing it. Adequate iodine does not eliminate the disease but appears to favor the less aggressive papillary form over the more dangerous follicular and anaplastic varieties.15PubMed Central. Iodine nutrition and papillary thyroid cancer
Hashimoto’s Thyroiditis and Thyroid Cancer Risk
Hashimoto’s thyroiditis, the most common cause of hypothyroidism, involves the immune system attacking the thyroid gland. People with Hashimoto’s face a higher risk of developing thyroid cancer, particularly the papillary type.16PubMed. Association of Hashimoto’s thyroiditis and thyroid cancer A large meta-analysis found that Hashimoto’s patients had roughly 1.5 to 2.4 times the odds of thyroid cancer compared with people without the condition, depending on the study design and how outlier studies were handled.17PubMed Central. Cancer Risk in Hashimoto’s Thyroiditis: a Systematic Review and Meta-Analysis One nationwide cohort study reported an even more striking association, though its wide confidence intervals suggest considerable uncertainty in the precise magnitude.18British Journal of Cancer. Cancer risk in patients with Hashimoto’s thyroiditis: a nationwide cohort study
Whether Hashimoto’s directly causes thyroid cancer or simply creates conditions that make detection more likely is genuinely debated. People with Hashimoto’s undergo more thyroid imaging and biopsies, which means small cancers that might otherwise go unnoticed are found. The chronic inflammation and elevated TSH levels that come with the disease could also plausibly promote tumor growth. The honest answer is that both mechanisms are probably at work: some of the elevated risk is real biology, and some is surveillance bias.
Obesity, Metabolic Syndrome, and Related Conditions
Being significantly overweight is associated with a higher chance of developing thyroid cancer. The proposed connection runs through the chronic low-grade inflammation, insulin resistance, and altered hormone levels that accompany excess body fat.19PubMed Central. Obesity and Thyroid Cancer Risk: An Update A large population-based study found that people with metabolic syndrome had about a 15 percent higher risk of thyroid cancer than those without it, and the risk rose to nearly 40 percent higher in people who had all five components of the syndrome present at once.20PubMed. Metabolic Syndrome and the Risk of Thyroid Cancer: A Nationwide Population-Based Cohort Study
A prospective cohort study looking at women specifically found that each five-unit increase in body mass index was associated with a 25 percent increase in thyroid cancer risk. Conditions like dyslipidemia and polycystic ovary syndrome (PCOS) also showed independent associations, and the PCOS link remained even after adjusting for weight, suggesting that hormonal and metabolic disruption matters beyond just the extra pounds.21The Lancet Regional Health – Americas. Association of excess adiposity and obesity-related metabolic conditions with thyroid cancer incidence in the Sister Study: a prospective cohort study
Environmental Chemicals Under Investigation
A growing body of research examines whether everyday chemical exposures contribute to thyroid cancer. Certain classes of chemicals, including flame retardants, polychlorinated biphenyls (PCBs), some phthalates, and specific pesticides, have shown potential associations with increased risk.22PubMed Central. Endocrine Disrupting Chemicals and Thyroid Cancer: An Overview These chemicals can interfere with thyroid hormone signaling, which is why they’re called endocrine disruptors.
One study measured flame retardant concentrations in household dust and found that people with higher levels of certain compounds had roughly double the odds of papillary thyroid cancer compared with those whose homes had lower levels.23PubMed. Exposure to flame retardant chemicals and occurrence and severity of papillary thyroid cancer: A case-control study Research on agricultural pesticides in California found associations between thyroid cancer and several widely used products, including paraquat dichloride and glyphosate, with risk increasing in proportion to the total number of different pesticides a person was exposed to.24The Journal of Clinical Endocrinology & Metabolism. Researchers examine link between pesticides and thyroid cancer risk in Central California area
The evidence here is less definitive than for radiation exposure. Most of these studies are observational, making it hard to rule out confounding factors. But the consistency of findings across different chemical classes and study populations is enough that researchers consider environmental endocrine disruptors a plausible contributor to rising thyroid cancer rates.
The Role of Increased Detection
Not all of the rising thyroid cancer incidence over the past few decades represents a true increase in disease. A substantial portion is driven by overdiagnosis, meaning the detection of small, slow-growing tumors that would never have caused symptoms or death if left undiscovered. Widespread use of neck ultrasound has been a major driver of this pattern.25PubMed Central. Unravelling the rise in thyroid cancer incidence and addressing overdiagnosis
South Korea provides the most dramatic example. When thyroid ultrasound screening was offered as an add-on to a national cancer screening program, thyroid cancer incidence surged to become the most commonly diagnosed cancer in the country. Most of the newly detected cancers were small papillary carcinomas with excellent prognoses, and the country’s thyroid cancer death rate barely changed.26The Lancet Diabetes & Endocrinology. Global trends in thyroid cancer incidence and the impact of overdiagnosis Excessive use of thyroid ultrasound, even in countries without formal screening programs, contributes to finding nodules that are then biopsied and sometimes diagnosed as cancer.27PubMed Central. Drivers of Thyroid Ultrasound Use: A Retrospective Observational Study
This does not mean thyroid cancer is harmless or that genuine increases in environmental risk factors play no role. Some of the rise in larger, more advanced tumors appears to be real and cannot be explained by screening alone. But if you or someone you know has been told about a small thyroid nodule found incidentally during an imaging test for something else, the overdiagnosis phenomenon is important context. Many expert groups now recommend against routine thyroid screening in people without symptoms or known risk factors.
The Curious Protective Effect of Smoking
In an unusual twist, smoking appears to lower thyroid cancer risk rather than raise it. A large cohort study found that male current smokers had about 42 percent lower risk of thyroid cancer compared with men who had never smoked, with a clear dose-dependent relationship (more pack-years, lower risk). In women, current smokers also trended toward lower risk, though the association was weaker.28PubMed Central. Cigarette smoking and thyroid cancer risk: a cohort study Meta-analyses of multiple studies have confirmed this inverse pattern.29PubMed. Thyroid cancer risk and smoking status: a meta-analysis
The likely explanation is that smoking lowers TSH levels, and TSH is a growth promoter for thyroid cells. In other words, smoking appears to suppress the hormonal signal that tells thyroid tissue to grow, which incidentally damps down the environment in which thyroid tumors develop. This is emphatically not a reason to smoke. The increased risk of lung cancer, heart disease, and dozens of other conditions overwhelms any marginal benefit against one particular cancer. But it illustrates how thyroid cancer risk factors sometimes run counter to intuition.
Geographic and Racial Patterns
Thyroid cancer rates vary considerably across populations, and the patterns don’t always track with the risk factors you’d expect. In the United States, White and Asian/Pacific Islander children have the highest rates of pediatric thyroid cancer, while Black and African American children have the lowest, with rates roughly a third of those in White children. There is also significant geographic clustering, with higher rates in Northeastern states and lower rates in the South.30PubMed. Racial/ethnic disparities and geographic clustering in pediatric thyroid cancer incidence in the United States, 1999-2022, with forecasts to 2027
Some of this variation likely reflects differences in access to healthcare and imaging. Populations with more routine medical care have more opportunities for incidental thyroid nodules to be found. But genetics also plays a role, since certain germline risk variants are more common in some ancestral populations than others. Disentangling genuine biological differences from differences in detection and treatment access is one of the more challenging problems in thyroid cancer epidemiology.
Age, Benign Nodules, and How Aggressiveness Shifts
Thyroid cancer can appear at any age, but its behavior changes depending on when it strikes. Younger patients tend to be diagnosed with less aggressive forms and have excellent survival rates, while those diagnosed after age 70 face a dramatically higher hazard of dying from the disease, with one study showing a 37-fold increase in mortality hazard compared with patients under 40.31PubMed Central. Survival from Differentiated Thyroid Cancer: What Has Age Got to Do with It? This does not mean older people are more likely to develop thyroid cancer. It means that when they do, the disease tends to be more aggressive and less responsive to standard treatments like radioactive iodine.
Thyroid nodules themselves are extremely common, especially with age. Most are benign. Studies estimate that somewhere between 5 and 15 percent of thyroid nodules turn out to be malignant.32PubMed Central. Thyroid Nodule Size and Prediction of Cancer: A Study at Tertiary Care Hospital in Saudi Arabia Having a nodule is not the same as having cancer, but nodules that grow, have irregular features on ultrasound, or appear in someone with risk factors like a history of radiation exposure or a strong family history warrant closer evaluation. Interestingly, larger nodules do not necessarily carry a higher cancer risk. Some data show that the proportion of malignant nodules is actually higher in smaller size ranges, which underscores why ultrasound characteristics matter more than size alone.